Unrelated donor bone marrow transplantation for Fanconi anemia

Bone Marrow Transplantation

Volumn 17, Issue 1, 1996, Pages 43-47

  Davies, S M ^a,b   Khan, S ^a,b   Wagner, J E ^a,b   Arthur, D C ^a   Auerbach, A D ^c   Ramsay, N K C ^a,b   Weisdorf, D J ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

DNA cross linking agents; Fanconi; Unrelated BMT

Indexed keywords

BUTADIENE DIEPOXIDE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BACTEREMIA; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; BONE PAIN; CHROMOSOME ABERRATION; CLINICAL ARTICLE; DRUG HYPERSENSITIVITY; FANCONI ANEMIA; FEMALE; GRAFT VERSUS HOST REACTION; HEMORRHAGIC CYSTITIS; HUMAN; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LIVER TOXICITY; MALE; MORTALITY; MUCOSA INFLAMMATION; MYCOSIS; MYELODYSPLASIA; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL RATE; VEIN OCCLUSION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; FANCONI ANEMIA; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0030071799     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Auerbach AD. Fanconi anemia. Dermatol Clin 1995; 13. 41-49.
2. Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 1993; 21: 731-733.
3. Butturini A, Gale RP, Verlander PC et al. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood 1994; 84: 1650-1655.
4. Gluckman E. Devergie A. Schaum G et al. Bone marrow transplantation in Fanconi's anaemia. Br J Haematol 1980; 45: 557-564.
5. Deeg JH, Storb R. Thomas ED et al. Fanconi's anemia treated by allogeneic marrow transplantation. Blood 1983; 61: 954-959.
6. Berger R, Bernheim A, Gluckman E. In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anaemia patients. Br J Haematol 1980; 45: 565-568.
7. Gluckman E. Devergie A, Dutreix J. Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol 1983; 54: 431-440.
8. Hows JM. Chapple M. Marsh JCW et al. Bone marrow transplantation for Fanconi's anaemia: the Hammersmith experience 1977-89. Bone Marrow Transplant 1989; 4: 629-634.
9. Kohli-Kumar M, Morris C. Delaat C et al. Bone marrow transplantation in Fanconi anemia using matched sibling donors. Blood 1994; 84: 2050-2054.
10. Di Bartolomeo P, Di Girolamo G, Olioso P et al. Allogeneic bone marrow transplantation for Fanconi anemia. Bone Marrow Transplant 1992; 10: 53-56.
11. Flowers MED, Doney KC, Storb R et al. Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience. Bone Marrow Transplant 1992; 9: 167-173.
12. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New Engl J Med 1993; 328: 593-602.
13. ISCN (1991). Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. F Mitelman (ed). S Karger: Basel, 1991.
14. Auerbach AD, Ghosh R, Pollio PC et al. Diepoxybutane test for prenatal and postnatal diagnosis of Fanconi anemia. In: Shcroeder-Kurth TM. Auerbach AD. Obe G (eds). Fanconi Anemia. Springer-Verlag: New York, 1989, pp 71-82.
15. Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood 1989; 73: 391-396.
16. Verlander PC. Lin JD, Udono MU et al. Mutation analysis of the Fanconi anemia gene FACC. Am J Hum Genet 1994; 54: 595-601.
17. Weisdorf D, Filipovich A, McGlave P et al. Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA (Xomazyme-CD5)) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation. Bone Marrow Transplant 1993; 12: 531-536.
18. Nash RA, Pepe MS. Storb R et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992; 80: 1838-1845.
19. Operations Manual, National Marrow Donor Program. Minneapolis MN, University of Minnesota: 1989, p. 6.10.
20. Perkins HA, Hansen JA. The US National Marrow Donor Program. Am J Pediatr Hemaiol Oncol 1994; 16: 30-34.
21. Gluckman E. Bone marrow transplantation in Fanconi's anemia. Stem Cells 1993; 11: 180-183.
22. Zanis-Neto J, Ribeiro RC, Medeiros C et al. Bone marrow transplantation for patients with Fanconi anemia: a study of 24 cases from a single institution. Bone Marrow Transplant 1995; 15: 293-298.
23. Davies SM, Ramsay NKC, Haake RJ et al. Comparison of engraftment in recipients of matched sibling or unrelated donor marrow allografts. Bone Marrow Transplant 1994; 13 51-57.
24. Giampietro PF, Adler-Brecher B, Verlander PC et al. The need for more accurate and timely diagnosis in Fanconi anemia: a report from the International Fanconi Anemia Registry. Pediatrics 1993; 91: 1116-1120.
25. Alter BP, Scalise A, McCombs J, Najfeld V. Clonal chromosomal abnormalities in Fanconi's anaemia: what do they really mean? Br J Haematol 1993; 85: 627-630.